☆ 4.8 Review

Murine models to study human NK cells in human solid tumors

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Humanized mouse models for immuno-oncology research

Jane Chuprin et al.

Summary: Immunotherapy has shown promise in treating various cancers, but there is still much to learn about its mechanisms of action and biomarkers of response. Humanized mice, which are mice engrafted with human tumors and immune components, offer several advantages for immuno-oncology research. This Review discusses the benefits and challenges of humanized mice and highlights the latest advances in their generation for potential clinical translation.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

Cancer plasticity: Investigating the causes for this agility

Shubhraneel Saha et al.

Summary: Cancer is an evolutionary disease, with cancer cells continuously adapting and evolving to meet their proliferation demands. This phenomenon, known as cancer plasticity, results in the formation of multiple subtypes of cancer cells with distinct phenotypes. Modern technologies such as single-cell RNA sequencing are crucial in understanding the rewiring of cancer cells. The processes and mechanisms that contribute to cancer plasticity, including genetic factors and environmental influences, have significant therapeutic implications.

SEMINARS IN CANCER BIOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors

Rohulla Vaseq et al.

Summary: Immunotherapy has significantly improved the survival rate of cancer patients, including lung cancer. Cytokine-induced killer (CIK) cell therapy has shown promise in lung cancer clinical trials, either alone or in combination with immune checkpoint inhibitors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Immunology

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

Philippa R. Kennedy et al.

Summary: This study examined the state of circulating mononuclear cells in NSCLC patients and found an immunosuppressive environment in advanced NSCLC, which limits treatment efficacy. The researchers designed a TriKE to enhance NK cell cytotoxicity against NSCLC targets, indicating its potential to improve current lung cancer therapies.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Oncology

Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer

Tal Flieswasser et al.

Summary: In this study, the cytotoxic and immune stimulatory potential of an anti-CD70 therapy in NSCLC was explored. The results showed that anti-CD70 therapy resulted in NK-mediated killing of NSCLC cells and increased production of pro-inflammatory cytokines by NK cells. Combination of chemotherapy and anti-CD70 therapy further enhanced NSCLC cell killing and improved survival in vivo.

ONCOIMMUNOLOGY (2023)

Add to Collection

Article Oncology

Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity

Mara P. Steinkamp et al.

CANCER RESEARCH COMMUNICATIONS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors

Guangyu Lian et al.

Summary: This article reviews the challenges encountered by NK cells in the solid tumor microenvironment and the therapeutic approaches to overcome these limitations. It also outlines the recent preclinical advances and the latest clinical outcomes of NK-based immunotherapies for solid tumors, as well as promising strategies to optimize current NK-targeted immunotherapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate

Rosemina Merchant et al.

Summary: MDNA11 is a next generation long-acting IL-2 immunotherapeutic that overcomes the limitations of current treatments by modifying receptor selectivity and extending the pharmacokinetic profile. It has been shown to control tumor growth and induce durable tumor clearance when used as a monotherapy or in combination with immune checkpoint inhibitors. Evaluation of MDNA11 in non-human primates demonstrates its good tolerability and the ability to stimulate a strong and durable immune response.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Article Otorhinolaryngology

Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model

Joseph Zenga et al.

Summary: This study investigates the effects of chronic stress induced by social isolation on tumor growth and human immune response in a mouse model with a humanized immune system. The results suggest that chronic stress increases tumor growth and metastasis, and leads to changes in tumor cell phenotype.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Add to Collection

Article Multidisciplinary Sciences

Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors

Natalie K. Wolf et al.

Summary: Cyclic dinucleotides and Toll-like receptor ligands can mobilize antitumor responses by natural killer cells and T cells, potentially serving as complementary therapies to immune checkpoint therapy. Combining cyclic dinucleotides with a half life-extended interleukin-2 can improve efficacy and induce long-term remissions in difficult to treat tumors.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Oncology

Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model

Yufei Wang et al.

Summary: Improving CAR-T cell therapy for solid tumors requires a better understanding of CAR design and cellular composition. A study found that CAR-T cells with a CD4/CD8 ratio of BB zeta exhibited superior efficacy in clearing clear-cell renal cell carcinoma (ccRCC) in a mouse model, demonstrating long-term tumor-free outcome.

MOLECULAR THERAPY-ONCOLYTICS (2022)

Add to Collection

Article Multidisciplinary Sciences

Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

Thomas Walle et al.

Summary: NK cells play a central role in the radiation-induced immune response, enhancing tumor control through the secretion of CXCL8/IL-8 and recruiting immune cells. This discovery suggests a rational cancer treatment strategy combining NK cells with radiotherapy.

SCIENCE ADVANCES (2022)

Add to Collection

Article Oncology

Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

Simona Caruso et al.

Summary: The study demonstrates the potential of using off-the-shelf CAR.CD123-NK cells as a therapeutic strategy for paediatric AML patients, showing significant anti-leukaemia activity and improved safety compared to CAR.CD123-T cells.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Enhanced development of functional human NK cells in NOD-scid-IL2rgnull mice expressing human IL15

Ken-Edwin Aryee et al.

Summary: Human innate immunity, including natural killer (NK) cells, plays a critical role in tumor surveillance and immunoregulation in the tumor microenvironment. Humanized mouse models have been developed to study human immuno-oncology, but the development and survival of human NK cells in these models are limited. Researchers have created a mouse model with constitutive expression of human Interleukin 15 (IL15) to enhance the development of functional human NK cells and limit tumor growth.

FASEB JOURNAL (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Interleukin 15 in Cell-Based Cancer Immunotherapy

Yang Zhou et al.

Summary: Cell-based cancer immunotherapy, especially using IL-15 as an immunostimulatory cytokine, has shown great potential in improving the therapeutic efficacy of current treatments. This review highlights the biology of IL-15, studies on its administration and its derivatives, and the advantages and challenges of incorporating IL-15 in cell-based immunotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Immunology

Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo

Pilar M. Lanuza et al.

Summary: This study reveals the immunological profile of CRC tumors in which immunogenicity and immune evasion mechanisms favor NK cell immunosurveillance at early disease stages. Additionally, allogeneic NK cell therapy can target tumors with mutations conferring poor prognosis regardless of the expression of T cell-related inhibitory immune checkpoint ligands.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy

Seung Hee Choi et al.

Summary: The chemical priming of NK cells using 25KbPEI enhances their antitumor activity and migration ability, offering a simple and cost-effective method for producing therapeutic NK cells.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Article Oncology

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

Michael F. Kaminski et al.

Summary: This study generated a Tri-specific Killer Engager (TriKE) against TEM8, which selectively activates NK cells to kill TEM8-expressing tumor cells and stromal cells, providing a novel anti-tumor, anti-stroma, and anti-angiogenic cancer therapy for patients with solid tumors.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Article Cell Biology

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant

Olivier Demaria et al.

Summary: This study presents the design of tetraspecific molecules that can activate natural killer cells for cancer therapy. The tetraspecific molecules selectively activate and proliferate natural killer cells, and the binding to tumor-associated antigens triggers cell cytotoxicity and cytokine production. In animal experiments, the tetraspecific molecules control tumor growth and accumulate at the tumor site. Furthermore, they can deplete circulating B cells without causing toxicity in non-human primates.

CELL REPORTS MEDICINE (2022)

Add to Collection

Review Immunology

Natural killer cells in antiviral immunity

Niklas K. Bjorkstrom et al.

Summary: This review explores the role of natural killer cells in acute and chronic viral infections, particularly focusing on insights from patients with primary immunodeficiencies. It also discusses the involvement of natural killer cells in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review highlights the importance of NK cells in innate immune responses to viral infections and provides recent insights into their role in human studies.

NATURE REVIEWS IMMUNOLOGY (2022)

Add to Collection

Review Oncology

Exploring the NK cell platform for cancer immunotherapy

Jacob A. Myers et al.

Summary: NK cells have innate potential to kill cancer cells, leading to the development of various NK cell-based therapies for cancer treatment. The main focus of NK cell therapy research is on optimizing sources of therapeutic NK cells and enhancing their cytotoxicity and persistence in the body.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

ETHICAL CONSIDERATIONS IN ANIMAL RESEARCH: THE PRINCIPLE OF 3R'S

Lorenza Diaz et al.

Summary: Over the past century, progress in human disease research, diagnosis, and treatment has been greatly aided by the use of laboratory animals. To ensure the proper and ethical use of experimental animals, training and guidance are essential. Animal research committees, particularly the IACUC, play a crucial role in evaluating research protocols and emphasizing animal welfare. Highlighting the importance of experimental research, the functions of IACUC, and the principles of the three R's (replacement, reduction, and refinement) can raise awareness among users of laboratory animals.

REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION (2021)

Add to Collection

Article Oncology

Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET

Marc Garcia-Moure et al.

Summary: The study demonstrated that Delta-24-RGD efficiently infected and replicated in various AT/RT and CNS-PNET cell lines, exhibiting significant cytotoxicity against tumor cells. In vivo, intratumoral injection of Delta-24-RGD significantly extended survival in mouse models of AT/RT and PNET, leading to long-term survival outcomes. Additionally, the viral therapy showed promising results in hindering tumor dissemination and increasing survival rates in immunocompetent humanized mouse models.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors

Irene Veneziani et al.

Summary: The study demonstrated that Nutlin-3a could enhance NK cell-mediated killing of neuroblastoma cells by restoring p53 function and increasing ligand expression for NK-ARs. Adoptive transfer of human NK cells into neuroblastoma-bearing mice resulted in tumor shrinkage and improved overall survival. Nutlin-3a also boosted NK cell-mediated cytotoxicity against neuroblastoma spheroids by increasing ligand expression in primary neuroblastoma cells.

CANCER IMMUNOLOGY RESEARCH (2021)

Add to Collection

Article Multidisciplinary Sciences

Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood

Demi Brownlie et al.

Summary: Recent studies have shown the existence of tissue-resident adaptive-like NK cells in the human lung and blood, which differ from traditional NK cells and exhibit enhanced cytotoxicity towards tumor cells. These cells may represent a novel strategy for targeted therapies against solid tumors.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Oncology

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Lucila N. Kerbauy et al.

Summary: The study suggests that using bispecific engagers and cytokine pre-activation can enhance NK-cell cytotoxicity against NK-resistant cancers. Additionally, there are differences in treatment response based on the source of NK cells.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors

Chia-Ing Jan et al.

Summary: The study introduces a novel CAR-NK strategy targeting HLA-G in solid tumors, which shows effective cytolytic action in vitro and in vivo. Combination therapy with low-dose chemotherapy enhances tumor ablation, suggesting a potential wide applicability in treating solid tumors.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Oncology

Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer

Minhua Chen et al.

Summary: NK cells have shown great potential in targeting various cancers, especially hematological malignancies, but their efficacy against solid tumors is limited. This study demonstrates that NK cells expanded using a feeder cell-free system derived from peripheral blood mononuclear cells have potent inhibitory effects on ovarian cancer growth. Adoptive transfer of expanded NK cells can reduce ascites formation and inhibit tumor growth in ovarian cancer mouse models. This highlights the promise of NK cell immunotherapy as a treatment strategy for ovarian cancers, including solid tumors and ascites.

CANCERS (2021)

Add to Collection

Article Immunology

Human KIT+ myeloid cells facilitate visceral metastasis by melanoma

Chun I. Yu et al.

Summary: Metastasis of melanoma significantly worsens prognosis; the CD33+CD11b+CD117+ myeloid cells could serve as a potential biomarker and therapeutic target for metastatic melanoma.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Sarcoma IL-12 overexpression facilitates NK cell immunomodulation

Mary Jo Rademacher et al.

Summary: Lentiviral transduction of sarcoma cells to express IL-12 can induce high-level expression of IL-12 and elicit specific immune responses in murine models, particularly mature human NK cells. IL-12 immunomodulation through autologous tumor transduction and reintroduction shows promise for sarcoma treatment and warrants further exploration.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Oncology

Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model

Yoke Seng Lee et al.

Summary: The study found that the number of CD141(+) dendritic cells in the blood of melanoma patients was significantly reduced, and these cells exhibited impaired function after peripheral stimulation. In non-responding patients, the number and function of these cells continued to decline during treatment. Indirectly expanding and activating CD141(+) dendritic cells in vivo with Flt3L and a TLR3 agonist can enhance the efficacy of anti-PD-1 treatment.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Review Oncology

Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy

Philipp Wendel et al.

Summary: In the last forty years, adoptive immunotherapy has seen advancements in utilizing immune cells for cancer treatment, with the use of NK cells, CIK cells, and specific T cell products. Recent developments have improved the effectiveness of immune cells in targeting tumor antigens via genetic engineering, offering promising outcomes in the fight against cancer.

CANCERS (2021)

Add to Collection

Article Oncology

Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy

Meng Guo et al.

Summary: The study developed a novel feeder-based NK cell expansion approach using OX40L-armed NK-92 cells, which induced a significant expansion of NK cells and exhibited high cytotoxicity. By promoting the OX40-OX40L positive feedback loop, the expanded NK cells showed enhanced function against tumor cells.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Memory-like Differentiation Enhances NK Cell Responses to Melanoma

Nancy D. Marin et al.

Summary: The treatment of advanced melanoma is a clinical challenge, and natural killer (NK) cells show promise as a cellular therapy. Cytokine-induced memory-like (ML) differentiation enhances NK-cell responses against blood cancer targets, but its activity against solid tumors like melanoma needs further research. In preclinical studies, ML NK cells from healthy donors and melanoma patients exhibited increased IFN gamma production and cytotoxicity against melanoma targets, with a response partially dependent on activating receptors NKG2D and NKp46. Furthermore, in mouse models, ML NK cells showed better control of melanoma compared to conventional NK cells.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Immunology

Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice

Xiaoyang Yue et al.

Summary: This study highlights the crucial role of B cells and sustained autoimmunity in the pathogenesis of SSc, demonstrated through a humanized mouse model. It provides a powerful tool for studying interstitial lung disease and other disease manifestations such as myositis and interstitial nephritis.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Oncology

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer

Daniel A. Vallera et al.

Summary: HER2 is a crucial marker in breast cancer therapy, but targeting it in ovarian cancer has shown disappointing results, requiring a more comprehensive approach. A new tri-specific biological drug has been designed to enhance NK cell killing of cancer cells and suppress tumor growth by delivering a natural cytokine signal. The study focuses on a nanobody platform technology that combines targeting and cytokine priming to improve efficacy in ovarian cancer treatment.

CANCERS (2021)

Add to Collection

Article Medicine, Research & Experimental

Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft

Duy Tri Le et al.

Summary: This study developed a novel solid tumor model, where TIL-PDX mice successfully engrafted with fresh solid tumors and harbored tumor-infiltrating lymphocytes, providing a valuable resource for future research.

JCI INSIGHT (2021)

Add to Collection

Article Oncology

An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer

Sandra D. Scherer et al.

Summary: This study developed an immune-humanized PDX model for studying endocrine-resistant ER+ breast cancer, which contains a naturally occurring ESR1 mutation and recapitulates the lymphocyte-excluded and myeloid-rich tumor microenvironment of human ER+ breast tumors. The model provides a platform for studying mechanisms of endocrine resistance and tumor-immune interactions in a clinically relevant in vivo setting.

BREAST CANCER RESEARCH (2021)

Add to Collection

Article Oncology

CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice

Jolien M. R. van der Meer et al.

Summary: The study found that combining HPC-NK cells with gemcitabine enhanced the killing effect on ovarian cancer, both in vitro and in vivo.

ONCOIMMUNOLOGY (2021)

Add to Collection

Article Oncology

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

J. M. R. Van der Meer et al.

Summary: N-803 is a promising IL-15-based compound that enhances HPC-NK cell expansion and functionality both in vitro and in vivo. Adding N-803 to HPC-NK cell therapy could potentially improve cancer immunotherapy.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection

Article Oncology

Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models

L. Ny et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Trans-endocytosis of intact IL-15Rα-IL-15 complex from presenting cells into NK cells favors signaling for proliferation

Olga M. Anton et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

SnapShot: Natural Killer Cells

Adeline Crinier et al.

CELL (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Human chimeric antigen receptor macrophages for cancer immunotherapy

Michael Klichinsky et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Review Oncology

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies

Rana Mhaidly et al.

CANCERS (2020)

Add to Collection

Article Hematology

NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles

Simona Caruso et al.

SEMINARS IN HEMATOLOGY (2020)

Add to Collection

Article Oncology

Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia

Melissa M. Berrien-Elliott et al.

CANCER DISCOVERY (2020)

Add to Collection

Article Immunology

Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source

Nicholas J. Hess et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Oncology

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

Daniel A. Vallera et al.

CANCERS (2020)

Add to Collection

Article Oncology

Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies

Adekunle Odunsi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Add to Collection

Review Oncology

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors

Gaurav Nayyar et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

Laurent Gauthier et al.

CELL (2019)

Add to Collection

Review Immunology

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation

Daniela Pende et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Immunology

An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More

Massimo Vitale et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Medicine, General & Internal

NK Cell-Based Immunotherapy for Hematological Malignancies

Simona Sivori et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Add to Collection

Article Oncology

HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice

Elin M. V. Forsberg et al.

CANCER RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression

Michael A. Brehm et al.

FASEB JOURNAL (2019)

Add to Collection

Article Oncology

Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells

Locke D. Uppendahl et al.

GYNECOLOGIC ONCOLOGY (2019)

Add to Collection

Article Hematology

Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models

Trisha R. Sippel et al.

BLOOD ADVANCES (2019)

Add to Collection

Article Biology

Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice

Masashi Matsuda et al.

LIFE SCIENCE ALLIANCE (2019)

Add to Collection

Article Hematology

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Rizwan Romee et al.

BLOOD (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Innovative Clinical Perspectives for CIK Cells in Cancer Patients

Martino Introna et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Review Cell Biology

Biology of IL-2 and its therapeutic modulation: Mechanisms and strategies

Suman Mitra et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Innate Lymphoid Cells: 10 Years On

Eric Vivier et al.

CELL (2018)

Add to Collection

Article Multidisciplinary Sciences

Improved multilineage human hematopoietic reconstitution and function in NSGS mice

Mark Wunderlich et al.

PLOS ONE (2018)

Add to Collection

Review Immunology

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

Lorenzo Mortara et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Oncology

Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors

Kim Margolin et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Review Immunology

Natural killer cells and other innate lymphoid cells in cancer

Laura Chiossone et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Add to Collection

Article Oncology

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer

M. Felices et al.

GYNECOLOGIC ONCOLOGY (2017)

Add to Collection

Review Immunology

The Broad Spectrum of Human Natural Killer Cell Diversity

Aharon G. Freud et al.

IMMUNITY (2017)

Add to Collection

Article Multidisciplinary Sciences

Humanized mouse model supports development, function, and tissue residency of human natural killer cells

Dietmar Herndler-Brandstetter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Add to Collection

Review Oncology

Three-dimensional cell culture: A powerful tool in tumor research and drug discovery

Donglai Lv et al.

ONCOLOGY LETTERS (2017)

Add to Collection

Article Multidisciplinary Sciences

Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model

Henrik Jespersen et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Oncology

Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice

Janneke S. Hoogstad-van Evert et al.

ONCOIMMUNOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15-transgenic NOG mouse

Ikumi Katano et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Oncology

Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival

Lijie Zhai et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Hematology

A functional DC cross talk promotes human ILC homeostasis in humanized mice

Silvia Lopez-Lastra et al.

BLOOD ADVANCES (2017)

Add to Collection

Article Cell Biology

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

Rizwan Romee et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Add to Collection

Article Oncology

Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4(+) T cell help

Jing Ni et al.

ONCOIMMUNOLOGY (2016)

Add to Collection

Article Oncology

Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma

Markus Granzin et al.

ONCOIMMUNOLOGY (2016)

Add to Collection

Review Oncology

Tumor-associated stromal cells as key contributors to the tumor microenvironment

Karen M. Bussard et al.

BREAST CANCER RESEARCH (2016)

Add to Collection

Article Oncology

Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis

Giulia Bertolini et al.

CANCER RESEARCH (2015)

Add to Collection

Article Immunology

Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function

Heinrich Schlums et al.

IMMUNITY (2015)

Add to Collection

Review Immunology

Role of NK cells in immunotherapy and virotherapy of solid tumors

Claudia Cantoni et al.

IMMUNOTHERAPY (2015)

Add to Collection

Article Immunology

Predominant Development of Mature and Functional Human NK Cells in a Novel Human IL-2-Producing Transgenic NOG Mouse

Ikumi Katano et al.

JOURNAL OF IMMUNOLOGY (2015)

Add to Collection

Article Biochemistry & Molecular Biology

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao et al.

NATURE MEDICINE (2015)

Add to Collection

Article Cell & Tissue Engineering

Nonirradiated NOD,B6.SCID Il2rγ-/- KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells

Brian E. McIntosh et al.

STEM CELL REPORTS (2015)

Add to Collection

Article Oncology

Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment

Monica Parodi et al.

ONCOIMMUNOLOGY (2015)

Add to Collection

Review Immunology

HLA-G: An Immune Checkpoint Molecule

Edgardo D. Carosella et al.

ADVANCES IN IMMUNOLOGY, VOL 127 (2015)

Add to Collection

Article Oncology

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

Dario Sangiolo et al.

CANCER RESEARCH (2014)

Add to Collection

Review Immunology

Effect of tumor cells and tumor microenvironment on NK-cell function

Massimo Vitale et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Development and function of human innate immune cells in a humanized mouse model

Anthony Rongvaux et al.

NATURE BIOTECHNOLOGY (2014)

Add to Collection

Review Immunology

Tissue-resident natural killer cells and their potential diversity

Dorothy K. Sojka et al.

SEMINARS IN IMMUNOLOGY (2014)

Add to Collection

Article Oncology

Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models

Despina Siolas et al.

CANCER RESEARCH (2013)

Add to Collection

Article Oncology

Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features

Loretta Gammaitoni et al.

CLINICAL CANCER RESEARCH (2013)

Add to Collection

Review Immunology

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediatec negative regulation of T cell responses

Alessandra Zingoni et al.

FRONTIERS IN IMMUNOLOGY (2013)

Add to Collection

Article Immunology

Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1

Ariella Glasner et al.

JOURNAL OF IMMUNOLOGY (2012)

Add to Collection

Article Multidisciplinary Sciences

Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'

Aron M. Levin et al.

NATURE (2012)

Add to Collection

Article Multidisciplinary Sciences

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Dimitrios N. Vatakis et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)

Add to Collection

Editorial Material Hematology

Multiple distinct NK-cell synapses

Emily M. Mace et al.

BLOOD (2011)

Add to Collection

Article Hematology

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

Antonio Curti et al.

BLOOD (2011)

Add to Collection

Article Biochemistry & Molecular Biology

IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization

Kai-Ping Han et al.

CYTOKINE (2011)

Add to Collection

Review Immunology

Natural Killer Cells and Solid Tumors

Ana Stojanovic et al.

JOURNAL OF INNATE IMMUNITY (2011)

Add to Collection

Article Hematology

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

Cyril Fauriat et al.

BLOOD (2010)

Add to Collection

Article Biotechnology & Applied Microbiology

Multicellular tumor spheroids: An underestimated tool is catching up again

Franziska Hirschhaeuser et al.

JOURNAL OF BIOTECHNOLOGY (2010)

Add to Collection

Review Immunology

Re-educating natural killer cells

Joseph C. Sun

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Add to Collection

Article Multidisciplinary Sciences

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

Francesca Bellora et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Add to Collection

Article Multidisciplinary Sciences

Reconstituting Organ-Level Lung Functions on a Chip

Dongeun Huh et al.

SCIENCE (2010)

Add to Collection

Article Immunology

Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex

M. A. King et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)

Add to Collection

Article Immunology

Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1

Gili G. Halfteck et al.

JOURNAL OF IMMUNOLOGY (2009)

Add to Collection

Article Virology

Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice

Diana M. Brainard et al.

JOURNAL OF VIROLOGY (2009)

Add to Collection

Article Multidisciplinary Sciences

Adaptive immune features of natural killer cells

Joseph C. Sun et al.

NATURE (2009)

Add to Collection

Article Immunology

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

Nadia Guerra et al.

IMMUNITY (2008)

Add to Collection

Article Allergy

Perturbations of natural killer cell regulatory functions in respiratory allergic diseases

Francesca Scordamaglia et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)

Add to Collection

Article Immunology

Accelerated tumor growth in mice deficient in DNAM-1 receptor

Akiko Iguchi-Manaka et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Add to Collection

Article Immunology

Interleukin-21 differentially affects human natural killer cell subsets

Katy Wendt et al.

IMMUNOLOGY (2007)

Add to Collection

Article Oncology

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma

Shuang Wei et al.

CANCER RESEARCH (2007)

Add to Collection

Article Biochemistry & Molecular Biology

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

Michael W. Melkus et al.

NATURE MEDICINE (2006)

Add to Collection

Article Hematology

IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients

M Ahmadzadeh et al.

BLOOD (2006)

Add to Collection

Review Immunology

Early liaisons between cells of the innate immune system in inflamed peripheral tissues

A Moretta et al.

TRENDS IN IMMUNOLOGY (2005)

Add to Collection

Article Hematology

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

F Ishikawa et al.

BLOOD (2005)

Add to Collection

Article Multidisciplinary Sciences

Licensing of natural killer cells by host major histocompatibility complex class I molecules

S Kim et al.

NATURE (2005)

Add to Collection

Article Oncology

A mouse mode of human breast cancer metastasis to human bone

C Kuperwasser et al.

CANCER RESEARCH (2005)

Add to Collection

Article Immunology

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells

LD Shultz et al.

JOURNAL OF IMMUNOLOGY (2005)

Add to Collection

Article Hematology

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

JS Miller et al.

BLOOD (2005)

Add to Collection

Article Multidisciplinary Sciences

Development of a human adaptive immune system in cord blood cell-transplanted mice

E Traggiai et al.

SCIENCE (2004)

Add to Collection

Article Immunology

IL-21 induces the functional maturation of murine NK cells

J Brady et al.

JOURNAL OF IMMUNOLOGY (2004)

Add to Collection

Article Multidisciplinary Sciences

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

G Ferlazzo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection

Article Hematology

NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells

M Ito et al.

BLOOD (2002)

Add to Collection

Article Immunology

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity

MT Kasaian et al.

IMMUNITY (2002)

Add to Collection

Article Hematology

Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells

L Rodella et al.

BRITISH JOURNAL OF HAEMATOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.